Erratum: Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia (2023) 37 10 (2006-2016))

Ze Tian; Chunhua Shi; Guojun Yang; Jason K. Allen; Qing Shi; Amin Al-Shami; Jill Wardell Olson; Melinda G. Smith; Qing Chang; Jasbir Kaur; Junping You; Timothy E. Lofton; Michelle A. Gonzalez; Qi Zhang; Dong Xing Zha; Sarah K. Tasian; Nitin Jain; Marina Y. Konopleva; Timothy Heffernan; Jeffrey J. Molldrem

doi:10.1038/s41375-023-02090-w

Erratum: Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia (2023) 37 10 (2006-2016))

Ze Tian, Chunhua Shi, Guojun Yang, Jason K. Allen, Qing Shi, Amin Al-Shami, Jill Wardell Olson, Melinda G. Smith, Qing Chang, Jasbir Kaur, Junping You, Timothy E. Lofton, Michelle A. Gonzalez, Qi Zhang, Dong Xing Zha, Sarah K. Tasian, Nitin Jain, Marina Y. Konopleva, Timothy Heffernan, Jeffrey J. Molldrem

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	226
Number of pages	1
Journal	Leukemia
Volume	38
Issue number	1
DOIs	https://doi.org/10.1038/s41375-023-02090-w
State	Published - Jan 1 2024

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-023-02090-w

Cite this

Tian, Z., Shi, C., Yang, G., Allen, J. K., Shi, Q., Al-Shami, A., Olson, J. W., Smith, M. G., Chang, Q., Kaur, J., You, J., Lofton, T. E., Gonzalez, M. A., Zhang, Q., Zha, D. X., Tasian, S. K., Jain, N., Konopleva, M. Y., Heffernan, T., & Molldrem, J. J. (2024). Erratum: Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia (2023) 37 10 (2006-2016)). Leukemia, 38(1), 226. https://doi.org/10.1038/s41375-023-02090-w

Tian, Z, Shi, C, Yang, G, Allen, JK, Shi, Q, Al-Shami, A, Olson, JW, Smith, MG, Chang, Q, Kaur, J, You, J, Lofton, TE, Gonzalez, MA, Zhang, Q, Zha, DX, Tasian, SK, Jain, N, Konopleva, MY, Heffernan, T & Molldrem, JJ 2024, 'Erratum: Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia (2023) 37 10 (2006-2016))', Leukemia, vol. 38, no. 1, pp. 226. https://doi.org/10.1038/s41375-023-02090-w

@article{b6aa5152e4c24684af16f7ccecf9bbb4,

title = "Erratum: Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia (2023) 37 10 (2006-2016))",

author = "Ze Tian and Chunhua Shi and Guojun Yang and Allen, {Jason K.} and Qing Shi and Amin Al-Shami and Olson, {Jill Wardell} and Smith, {Melinda G.} and Qing Chang and Jasbir Kaur and Junping You and Lofton, {Timothy E.} and Gonzalez, {Michelle A.} and Qi Zhang and Zha, {Dong Xing} and Tasian, {Sarah K.} and Nitin Jain and Konopleva, {Marina Y.} and Timothy Heffernan and Molldrem, {Jeffrey J.}",

year = "2024",

month = jan,

day = "1",

doi = "10.1038/s41375-023-02090-w",

language = "English (US)",

volume = "38",

pages = "226",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia (2023) 37 10 (2006-2016))

AU - Tian, Ze

AU - Shi, Chunhua

AU - Yang, Guojun

AU - Allen, Jason K.

AU - Shi, Qing

AU - Al-Shami, Amin

AU - Olson, Jill Wardell

AU - Smith, Melinda G.

AU - Chang, Qing

AU - Kaur, Jasbir

AU - You, Junping

AU - Lofton, Timothy E.

AU - Gonzalez, Michelle A.

AU - Zhang, Qi

AU - Zha, Dong Xing

AU - Tasian, Sarah K.

AU - Jain, Nitin

AU - Konopleva, Marina Y.

AU - Heffernan, Timothy

AU - Molldrem, Jeffrey J.

PY - 2024/1/1

Y1 - 2024/1/1

UR - http://www.scopus.com/inward/record.url?scp=85182091083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85182091083&partnerID=8YFLogxK

U2 - 10.1038/s41375-023-02090-w

DO - 10.1038/s41375-023-02090-w

M3 - Comment/debate

C2 - 38036631

AN - SCOPUS:85182091083

SN - 0887-6924

VL - 38

SP - 226

JO - Leukemia

JF - Leukemia

IS - 1

ER -

Erratum: Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia (2023) 37 10 (2006-2016))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this